AT326674B - Verfahren zur herstellung neuer naphthyridinderivaten - Google Patents

Verfahren zur herstellung neuer naphthyridinderivaten

Info

Publication number
AT326674B
AT326674B AT412471A AT412471A AT326674B AT 326674 B AT326674 B AT 326674B AT 412471 A AT412471 A AT 412471A AT 412471 A AT412471 A AT 412471A AT 326674 B AT326674 B AT 326674B
Authority
AT
Austria
Prior art keywords
naphthyride
derivatives
new
production
new naphthyride
Prior art date
Application number
AT412471A
Other languages
German (de)
English (en)
Other versions
ATA412471A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH708670A external-priority patent/CH527196A/de
Priority claimed from CH708970A external-priority patent/CH527822A/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA412471A publication Critical patent/ATA412471A/de
Application granted granted Critical
Publication of AT326674B publication Critical patent/AT326674B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT412471A 1970-05-13 1971-05-12 Verfahren zur herstellung neuer naphthyridinderivaten AT326674B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH708670A CH527196A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphthyridinderivate
CH708970A CH527822A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate

Publications (2)

Publication Number Publication Date
ATA412471A ATA412471A (de) 1975-03-15
AT326674B true AT326674B (de) 1975-12-29

Family

ID=25700728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT412471A AT326674B (de) 1970-05-13 1971-05-12 Verfahren zur herstellung neuer naphthyridinderivaten

Country Status (14)

Country Link
JP (1) JPS5432799B1 (cs)
AT (1) AT326674B (cs)
CA (1) CA970377A (cs)
CS (2) CS167202B2 (cs)
DE (1) DE2123328A1 (cs)
DK (1) DK134488B (cs)
ES (1) ES391026A1 (cs)
FI (1) FI52089C (cs)
FR (1) FR2100649B1 (cs)
GB (1) GB1361441A (cs)
NL (1) NL7106502A (cs)
PL (1) PL76913B1 (cs)
SE (1) SE387640B (cs)
SU (1) SU423296A3 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
NL7314396A (cs) * 1972-10-26 1974-05-01
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine
AU8106598A (en) * 1997-06-03 1998-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
BRPI0510951A (pt) * 2004-05-12 2007-11-20 Pfizer Prod Inc derivados de piperidina como antagonistas de nk1 e nk3
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Also Published As

Publication number Publication date
FI52089B (cs) 1977-02-28
DK134488B (da) 1976-11-15
DK134488C (cs) 1977-05-16
CS162753B2 (cs) 1975-07-15
GB1361441A (en) 1974-07-24
FR2100649B1 (cs) 1974-08-30
CS167202B2 (cs) 1976-04-29
SE387640B (sv) 1976-09-13
PL76913B1 (en) 1975-02-28
SU423296A3 (ru) 1974-04-05
CA970377A (en) 1975-07-01
FR2100649A1 (cs) 1972-03-24
JPS5432799B1 (cs) 1979-10-16
ES391026A1 (es) 1974-04-01
FI52089C (fi) 1977-06-10
DE2123328A1 (de) 1971-12-02
NL7106502A (cs) 1971-11-16
ATA412471A (de) 1975-03-15

Similar Documents

Publication Publication Date Title
CH531000A (de) Verfahren zur Herstellung neuer Benzocycloheptathiophene
AT311315B (de) Verfahren zur Herstellung neuer Alkoxydinitroaniline
ATA412471A (de) Verfahren zur herstellung neuer naphthyridinderivaten
CH532040A (de) Verfahren zur Herstellung neuer Indolderivate
CH508627A (de) Verfahren zur Herstellung neuer Hexahydrobenzazocine
AT306256B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
AT303272B (de) Verfahren zur Herstellung neuer Evomonosid-Derivate
CH535730A (de) Verfahren zur Herstellung neuer Naphthylalkanole
CH518251A (de) Verfahren zur Herstellung neuer Prostaglandinderivate
AT307617B (de) Verfahren zur Herstellung neuer Penicilline
AT306924B (de) Verfahren zur Herstellung neuer Penicilline
AT305266B (de) Verfahren zur Herstellung neuer substituierter 2-Benzylphenole
AT305273B (de) Verfahren zur Herstellung neuer Benzofuranderivate
CH535762A (de) Verfahren zur Herstellung neuer Indolderivate
AT295512B (de) Verfahren zur Herstellung neuer Pyrrolderivate
AT319608B (de) Verfahren zur Herstellung neuer Polyepoxydpolysiloxane
CH533633A (de) Verfahren zur Herstellung neuer Phenanthrotriazolylderivate
CH498817A (de) Verfahren zur Herstellung neuer Isothiocyanato-diphenylamine
CH511885A (de) Verfahren zur Herstellung neuer Furanonderivate
AT308114B (de) Verfahren zur Herstellung neuer Piperidinderivate
CH530387A (de) Verfahren zur Herstellung neuer Furano-Derivate
AT307632B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstan-derivate
AT319224B (de) Verfahren zur Herstellung neuer Nitrofuranderivate
CH542828A (de) Verfahren zur Herstellung neuer Thioharnstoffe
AT299941B (de) Verfahren zur Herstellung neuer Thiazolderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee